IBDEI1H6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25044,0)
 ;;=F78.^^93^1127^5
 ;;^UTILITY(U,$J,358.3,25044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25044,1,3,0)
 ;;=3^Intellectual Disabilities,Oth Specified
 ;;^UTILITY(U,$J,358.3,25044,1,4,0)
 ;;=4^F78.
 ;;^UTILITY(U,$J,358.3,25044,2)
 ;;=^5003672
 ;;^UTILITY(U,$J,358.3,25045,0)
 ;;=F79.^^93^1127^6
 ;;^UTILITY(U,$J,358.3,25045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25045,1,3,0)
 ;;=3^Intellectual Disabilities,Unspec
 ;;^UTILITY(U,$J,358.3,25045,1,4,0)
 ;;=4^F79.
 ;;^UTILITY(U,$J,358.3,25045,2)
 ;;=^5003673
 ;;^UTILITY(U,$J,358.3,25046,0)
 ;;=Z00.6^^93^1128^1
 ;;^UTILITY(U,$J,358.3,25046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25046,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,25046,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,25046,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,25047,0)
 ;;=F45.22^^93^1129^1
 ;;^UTILITY(U,$J,358.3,25047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25047,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,25047,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,25047,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,25048,0)
 ;;=F45.20^^93^1129^7
 ;;^UTILITY(U,$J,358.3,25048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25048,1,3,0)
 ;;=3^Hypochondiacal Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25048,1,4,0)
 ;;=4^F45.20
 ;;^UTILITY(U,$J,358.3,25048,2)
 ;;=^5003586
 ;;^UTILITY(U,$J,358.3,25049,0)
 ;;=F45.21^^93^1129^9
 ;;^UTILITY(U,$J,358.3,25049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25049,1,3,0)
 ;;=3^Hypochondriasis
 ;;^UTILITY(U,$J,358.3,25049,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,25049,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,25050,0)
 ;;=F45.29^^93^1129^8
 ;;^UTILITY(U,$J,358.3,25050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25050,1,3,0)
 ;;=3^Hypochondriacal Disorders NEC
 ;;^UTILITY(U,$J,358.3,25050,1,4,0)
 ;;=4^F45.29
 ;;^UTILITY(U,$J,358.3,25050,2)
 ;;=^5003589
 ;;^UTILITY(U,$J,358.3,25051,0)
 ;;=F45.8^^93^1129^15
 ;;^UTILITY(U,$J,358.3,25051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25051,1,3,0)
 ;;=3^Somatoform Disorders NEC
 ;;^UTILITY(U,$J,358.3,25051,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,25051,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,25052,0)
 ;;=F45.41^^93^1129^10
 ;;^UTILITY(U,$J,358.3,25052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25052,1,3,0)
 ;;=3^Pain Disorder Exclusively Related to Psychological Factors
 ;;^UTILITY(U,$J,358.3,25052,1,4,0)
 ;;=4^F45.41
 ;;^UTILITY(U,$J,358.3,25052,2)
 ;;=^5003590
 ;;^UTILITY(U,$J,358.3,25053,0)
 ;;=F45.42^^93^1129^11
 ;;^UTILITY(U,$J,358.3,25053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25053,1,3,0)
 ;;=3^Pain Disorder w/ Related Psychological Factors
 ;;^UTILITY(U,$J,358.3,25053,1,4,0)
 ;;=4^F45.42
 ;;^UTILITY(U,$J,358.3,25053,2)
 ;;=^5003591
 ;;^UTILITY(U,$J,358.3,25054,0)
 ;;=F45.0^^93^1129^13
 ;;^UTILITY(U,$J,358.3,25054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25054,1,3,0)
 ;;=3^Somatization Disorder
 ;;^UTILITY(U,$J,358.3,25054,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,25054,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,25055,0)
 ;;=F45.9^^93^1129^14
 ;;^UTILITY(U,$J,358.3,25055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25055,1,3,0)
 ;;=3^Somatoform Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25055,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,25055,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,25056,0)
 ;;=F45.1^^93^1129^16
 ;;^UTILITY(U,$J,358.3,25056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25056,1,3,0)
 ;;=3^Undifferntiated Somatoform Disorder
 ;;^UTILITY(U,$J,358.3,25056,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,25056,2)
 ;;=^5003585
